{
    "eid": "2-s2.0-85122130721",
    "title": "In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Drug-repositioning",
        "Glide docking",
        "MD simulation",
        "MEK inhibitor",
        "MM/GBSA",
        "MM/PBSA"
    ],
    "authors": [
        "Muthu Kumar Thirunavukkarasu",
        "Utid Suriya",
        "Thanyada Rungrotmongkol",
        "Ramanathan Karuppasamy"
    ],
    "citedby-count": 9,
    "ref-count": 58,
    "ref-list": [
        "Recognising lung cancer in primary care",
        "Lung cancer: Prevalent trends & emerging concepts",
        "Nanotechnology: Breaking the current treatment limits of lung cancer",
        "The emerging treatment landscape of targeted therapy in non-small-cell lung cancer",
        "Epidermal growth factor receptor mutations in lung cancer",
        "Mek inhibitors for the treatment of non-small cell lung cancer",
        "K-RAS (G12C) inhibitors allosterically control GTP affinity and effector interactions",
        "Targeting alterations in the RAF\u2013MEK pathway",
        "Allosteric and ATP-competitive MEK-inhibition in a novel spitzoid melanoma model with a RAF-and phosphorylation-independent mutation",
        "Targeting of MEK in lung cancer therapeutics",
        "The clinical development of MEK inhibitors",
        "Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma",
        "Fda approval summary: Dabrafenib and trametinib for the treatment of metastatic non-small cell lung cancers harboring BRAF V600E mutations",
        "Ocular toxicity of targeted therapies",
        "Combination of MEK inhibitor and the JAK2-STAT3 pathway inhibition for the therapy of colon cancer",
        "Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer",
        "Phase I studies of azd1208, a proviral integration moloney virus kinase inhibitor in solid and haematological cancers",
        "Systematic functional characterization of resistance to PI3K inhibition in breast cancer",
        "How were new medicines discovered?",
        "Performing an in silico repurposing of existing drugs by combining virtual screening and molecular dynamics simulation",
        "Performance of machine-learning scoring functions in structure-based virtual screening",
        "Discovery of imidazopyridazines as potent PIM-1/2 kinase inhibitors",
        "Multi-dimensional screening strategy for drug repurposing with statistical framework\u2014 A new road to influenza drug discovery",
        "Identifying and characterizing binding sites and assessing druggability",
        "In silico assessment of potential druggable pockets on the surface of \u03b11-antitrypsin conformers",
        "Novel urushiol derivatives as HDAC8 inhibitors: Rational design, virtual screening, molecular docking and molecular dynamics studies",
        "Interaction analysis of T7 RNA polymerase with heparin and its low molecular weight derivatives\u2014An in silico approach",
        "A machine learning approach to predicting protein\u2013ligand binding affinity with applications to molecular docking",
        "Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance",
        "Development and testing of a general amber force field",
        "Comparison of simple potential functions for simulating liquid water",
        "Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation",
        "Butoxy mansonone G inhibits STAT3 and AKT signaling pathways in non-small cell lung cancers: Combined experimental and theoretical investigations",
        "Key binding and susceptibility of NS3/4A serine protease inhibitors against hepatitis C virus",
        "Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms",
        "Binding recognition of substrates in NS2B/NS3 serine protease of zika virus revealed by molecular dynamics simulations",
        "Particle mesh ewald: An N\u00b7log(N) method for ewald sums in large systems",
        "Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes",
        "Synchronization of trajectories in canonical molecular-dynamics simulations: Observation, explanation, and exploitation",
        "Molecular dynamics with coupling to an external bath",
        "Solvated interaction energy (SIE) for scoring protein\u2212ligand binding affinities. 1. Exploring the parameter space",
        "Druggability analysis and classification of protein tyrosine phosphatase active sites",
        "Mek1/2 inhibitors: Molecular activity and resistance mechanisms",
        "Deep docking: A deep learning platform for augmentation of structure based drug discovery",
        "Chemmine tools: An online service for analyzing and clustering small molecules",
        "Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors",
        "In silico docking, molecular dynamics and binding energy insights into the bolinaquinoneclathrin terminal domain binding site",
        "Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT1 and ETa receptor antagonists",
        "Pyridine moiety: Recent advances in cancer treatment",
        "Discovery of drug-like acetylcholinesterase inhibitors by rapid virtual screening of a 6.9 million compound database",
        "MEK1/2 dual-specificity protein kinases: Structure and regulation",
        "Insights into the binding mode of MEK Type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinome",
        "Psychotropic drugs show anticancer activity by disrupting mitochondrial and lysosomal function",
        "Exploration of N-(2-aminoethyl) piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and ABL-1 multikinase inhibitor",
        "An insight into the therapeutic potential of quinazoline derivatives as anticancer agents",
        "Insights into protein-ligand interactions: Mechanisms, models, and methods"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Vellore",
            "@id": "60010618",
            "affilname": "Vellore Institute of Technology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010618",
            "affiliation-country": "India"
        }
    ],
    "funding": [
        "Science Achievement Scholarship",
        "Chulalongkorn University",
        "Thailand Research Fund",
        "SAST"
    ]
}